The challenges to detect, quantify, and characterize viral reservoirs in the current antiretroviral era.

NeuroImmune pharmacology and therapeutics Pub Date : 2024-12-05 eCollection Date: 2024-09-01 DOI:10.1515/nipt-2024-0017
Hector Gutierrez, Eliseo A Eugenin
{"title":"The challenges to detect, quantify, and characterize viral reservoirs in the current antiretroviral era.","authors":"Hector Gutierrez, Eliseo A Eugenin","doi":"10.1515/nipt-2024-0017","DOIUrl":null,"url":null,"abstract":"<p><p>A major barrier to cure HIV is the early generation of viral reservoirs in tissues. These viral reservoirs can contain intact or defective proviruses, but both generates low levels of viral proteins contribute to chronic bystander damage even in the ART era. Most viral reservoir detection techniques are limited to blood-based, reactivation, and sequencing assays that lack spatial properties to examine the contribution of the host's microenvironment to latency and cure efforts. Currently, little is known about the contribution of the microenvironment to viral reservoir survival, residual viral expression, and associated inflammation. Only a few spatiotemporal techniques are available, and fewer integrate spatial genomics, transcriptomics, and proteomics into the analysis of the viral reservoir microenvironment-all essential components to cure HIV. During the development of these spatial techniques, many considerations need to be included in the analysis to avoid misinterpretation. This manuscript tries to clarify some critical concepts in viral reservoir detection by spatial techniques and the upcoming opportunities for cure efforts.</p>","PeriodicalId":74278,"journal":{"name":"NeuroImmune pharmacology and therapeutics","volume":"3 3-4","pages":"211-219"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11751450/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NeuroImmune pharmacology and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/nipt-2024-0017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A major barrier to cure HIV is the early generation of viral reservoirs in tissues. These viral reservoirs can contain intact or defective proviruses, but both generates low levels of viral proteins contribute to chronic bystander damage even in the ART era. Most viral reservoir detection techniques are limited to blood-based, reactivation, and sequencing assays that lack spatial properties to examine the contribution of the host's microenvironment to latency and cure efforts. Currently, little is known about the contribution of the microenvironment to viral reservoir survival, residual viral expression, and associated inflammation. Only a few spatiotemporal techniques are available, and fewer integrate spatial genomics, transcriptomics, and proteomics into the analysis of the viral reservoir microenvironment-all essential components to cure HIV. During the development of these spatial techniques, many considerations need to be included in the analysis to avoid misinterpretation. This manuscript tries to clarify some critical concepts in viral reservoir detection by spatial techniques and the upcoming opportunities for cure efforts.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在当前抗逆转录病毒时代检测、量化和表征病毒库的挑战。
治愈艾滋病毒的一个主要障碍是组织中早期产生的病毒库。这些病毒储存库可以包含完整的或有缺陷的前病毒,但即使在抗逆转录病毒治疗时代,两者都产生低水平的病毒蛋白,导致慢性旁观者损伤。大多数病毒库检测技术仅限于血液、再激活和测序分析,缺乏空间特性来检查宿主微环境对潜伏期和治愈效果的贡献。目前,人们对微环境对病毒库存活、残留病毒表达和相关炎症的影响知之甚少。只有少数时空技术可用,更少将空间基因组学、转录组学和蛋白质组学整合到病毒库微环境的分析中——这些都是治愈HIV的重要组成部分。在这些空间技术的发展过程中,需要在分析中考虑许多因素,以避免误解。本文试图澄清一些关键的概念,在病毒库检测的空间技术和即将到来的治愈努力的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Loss of AMPK potentiates inflammation by activating the infammasome in a preclinical mouse model of TBI. Analyses of astrocyte-neuron lactate shuttle transporter levels in brain tissues from people with HIV-associated neurocognitive impairment and Alzheimer's disease. CEST MRI assessment of HIV-1-associated neurometabolic impairments in a humanized mouse model. S-Equol: a novel therapeutic for HIV-1-associated gastrointestinal dysbiosis. Extracellular vesicle-based therapies for neurodegenerative diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1